▼ SELL
$ Value
$16K
Shares
5,579
Price
$3
Filed
May 13
Insider
Name
Yu Yong
Title
VP, Clinical Trial Operations
CIK
0001937482
Roles
Officer
Transaction Details
Transaction Date
2025-05-12
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
47,640
Footnotes
Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.
Filing Info
Yu Yong's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-24 | GNLX | ▼ | $2K |
| 2025-11-17 | GNLX | ▼ | $5K |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-08-27 | GNLX | A | $0 |
| 2025-08-27 | GNLX | A | $0 |
| 2025-08-21 | GNLX | ▼ | $11K |
| 2025-05-12 | GNLX | ▼ | $16K |
Other Insiders at GNLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Yu Yong / Cappello Joseph
SVP, Clinical Development
|
— | $2K | 2026-03-24 |
|
Zindrick Thomas
President and CEO
|
— | $9K | 2026-03-24 |
| Thomas John | — | $29K | 2026-03-02 |
|
Smalling Ralph
Head of Regulatory
|
— | $1K | 2026-03-25 |